BTHE

Boston Therapeutics, Inc. BTHE

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BTHE BNOEF TBPMF IMUN MXDHF FLWPF POLXF FWPAY LVCLY HBCNF
6M 0.00 % -71.43 % -95.45 % -81.40 % 24 900.00 % 0.00 % 261.09 % 14 900.00 % -31.45 % -76.19 %
YTD 0.00 % -70.00 % -95.50 % -84.50 % -96.03 % 900.00 % 261.09 % -25.00 % -38.80 % 2 269.67 %
1Y 0.00 % -85.52 % -96.25 % -91.14 % -95.83 % 900.00 % 133.65 % -68.31 % -54.33 % -66.67 %
3Y 0.00 % -94.20 % -99.26 % -99.42 % -97.40 % -99.95 % 133.65 % -86.82 % -69.40 % -84.62 %
5Y 0.00 % -95.00 % -99.90 % -98.89 % -98.63 % -100.00 % 85.61 % -90.06 % -69.82 % -84.62 %
10Y 0.00 % -98.95 % -97.80 % -100.00 % -99.61 % -100.00 % 145.19 % -99.27 % -93.05 % -84.62 %
From the beginning 0.00 % -98.13 % -99.71 % -99.99 % -99.61 % -100.00 % -95.65 % -99.27 % -96.81 % -84.62 %

Dividend

Forward Pharma A/S